| Net Loss | |
| Stock compensation expense | 884.17K |
| Stock issued under stock purchase plan | |
| Fair value adjustment of common stock warrants EITF 07-05 (Topic 815) | |
| Depreciation and amortization - continuing operations | 2.13M |
| Depreciation and amortization - discontinued operations | |
| Loss on disposal of property and equipment - discontinuing operations | |
| Loss on disposal of property and equipment - continuing operations | |
| Change in value of unconsolidated affiliate | |
| Prepaid expenses and other assets | |
| Accounts payable | -1.78M |
| Accrued expenses and other current liabilities | 500.88K |
| Accounts receivables and Other receivables | |
| Provision for doubtful accounts and sales returns allowances | |
| Inventories, net | |
| Prepaid expenses and other current assets | |
| Accounts payable | |
| Accrued expenses and other current liabilities | |
| Accrued product warranty | |
| Deferred revenue | |
| Net cash used in operating activities | |
| Acquisition of property and equipment - continuing operations | -36.73K |
| Notes Receivable for asset disposition | |
| Net cash provided by investing activities: | |
| Net cash used in financing activities | |
| Effect of exchange rates on cash and cash equivalents | |
| Net decrease in cash and cash equivalents | |
| Cash and cash equivalents at beginning of period | |
| Cash and cash equivalents at end of period | |
| Transfer of demo lab equipment between inventory (USA) and fixed assets (France) | |